Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy ObsEva (OBSV) stocks

Learn how to easily invest in ObsEva stocks.

ObsEva is a biotechnology business based in the US. ObsEva stocks (OBSV.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $2.8 – an increase of 5% over the previous week. ObsEva employs 48 staff and has a trailing 12-month revenue of around $2.2 million.

How to buy stocks in ObsEva

  1. Compare stock trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – OBSV – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of stocks with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

ObsEva stock price (NASDAQ:OBSV)

Use our graph to track the performance of OBSV stocks over time.

ObsEva shares at a glance

Information last updated 2022-06-24.
Latest market close$1.89
52-week range$1.08 - $3.58
50-day moving average $1.66
200-day moving average $1.97
Wall St. target price$9.50
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.64

Compare stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 6 of 6
Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95–$6.95
$0 if conditions met, otherwise $100 a year
Stocks, Bonds, Options, Mutual Funds, ETFs
Young investors 18 to 24 can get free online trades and a $0 annual account fee. Conditions apply.
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99–$9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
FREE TRADES
Wealthsimple
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get $25 when you open a Wealthsimple account and fund at least $150.
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
OFFER
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get almost $500 in commission free trades when you fund your new account with a minimum of $10,000. Conditions apply. Ends August 31, 2022.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy ObsEva stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

ObsEva price performance over time

Historical closes compared with the close of $1.89 from 2022-06-24

1 week (2022-06-21) 6.78%
1 month (2022-05-27) 6.78%
3 months (2022-03-24) 34.04%
6 months (2021-12-24) N/A
1 year (2021-06-28) -38.03%
2 years (2020-06-26) -66.90%
3 years (2019-06-28) 11.31
5 years (2017-06-27) 6.31

ObsEva financials

Revenue TTM $2.2 million
Gross profit TTM $17,000
Return on assets TTM -31.26%
Return on equity TTM -129.6%
Profit margin 0%
Book value $0.33
Market capitalisation $156.5 million

TTM: trailing 12 months

ObsEva share dividends

We're not expecting ObsEva to pay a dividend over the next 12 months.

Have ObsEva's shares ever split?

ObsEva's shares were split on a 13:1 basis on 5 December 2016. So if you had owned 1 share the day before before the split, the next day you'd have owned 13 shares. This wouldn't directly have changed the overall worth of your ObsEva shares – just the quantity. However, indirectly, the new 92.3% lower share price could have impacted the market appetite for ObsEva shares which in turn could have impacted ObsEva's share price.

ObsEva share price volatility

Over the last 12 months, ObsEva's shares have ranged in value from as little as $1.08 up to $3.58. A popular way to gauge a stock's volatility is its "beta".

OBSV.US volatility(beta: 0.65)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ObsEva's is 0.6529. This would suggest that ObsEva's shares are less volatile than average (for this exchange).

ObsEva overview

ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometriosis and heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. The company is also involved in developing Ebopiprant, an oral and selective prostaglandin F2a, or PGF2a receptor antagonist, which is in Phase II clinical trial as a once daily treatment for preterm labor in weeks 24 to 34 of gestational age; and Nolasiban, an oral oxytocin receptor antagonist that is in Phase I clinical trial to enhance clinical pregnancy and live birth rates in women undergoing in vitro fertilization. ObsEva SA was founded in 2012 and is headquartered in Geneva, Switzerland. .

Frequently asked questions


Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site